Articles tagged with Broad Spectrum Antibiotics
UCF researcher Mollie Jewett aims to 'starve' Borrelia burgdorferi of nutrients to prevent Lyme disease spread. Her team is focused on targeting the bacteria's ability to consume riboflavin, a key nutrient for its survival.
Researchers found that over-the-counter probiotics contain only 36 unique species of bacteria, with most common species being forms of Lactobacillus. The analysis suggests a lack of consistency in the combination of species used to support gut health and vaginal health claims.
A long-term public study found that phytochemicals from oregano and rosemary supported favorable gut health and growth performance in weaned pigs, preserving microbial diversity to improve nutrient utilization. The natural agents outperformed antibiotic growth promoters in terms of final body weight and gain-to-feed ratio.
Phyton Biotech has successfully transferred the manufacturing process for Corallopyronin A (CorA), a novel anti-infective agent with potent activity against filarial infections and bacterial infections. The technology transfer marks an important milestone in the Company's specialty GMP fermentation capabilities.
The Ann Arbor Guide provides two algorithms for triaging adults with suspected UTIs, one for non-pregnant women and the other for men. It also emphasizes the importance of accurate testing and treatment to prevent overuse of antibiotics and antibiotic resistance.
Researchers have demonstrated that doxycycline can improve survival rates and neurological outcomes in children with Central Nervous System Tuberculosis. The study found that treating CNS-TB laboratory models with doxycycline alongside standard TB drugs suppressed inflammation, preserved brain tissue, and improved vascular integrity.
A University of Leicester-led study reveals that around one in three hospital infections involve antimicrobial resistance, independently associated with a higher risk of death. The study found patients with resistant infections had a 58% increased risk of mortality compared to those with susceptible infections.
A study analyzed antibiotic prescribing patterns in Arkansas Medicaid's patient-centered medical home (PCMH) program. The results showed a decrease in pediatric and adult age group claims, with clinics that prescribed the least antibiotics having lower rates in 2021 compared to previous years.
The book examines antibiotic-induced reproductive toxicity, microbiome alterations, and emerging concerns around antibiotic resistance. It provides critical insights for clinicians, pharmacists, researchers, and students in reproductive medicine and pharmacology.
A study found that early antibiotics exposure can impair infant immune systems, disrupting lung immunity and making them vulnerable to respiratory infections. Supplementing with a naturally occurring metabolite called inosine may help restore their ability to fight such infections.
Researchers found pandrug-resistant Klebsiella pneumoniae in Ukrainian war victims, showing high virulence and rapid spread. The bacteria's ability to cause disease remains despite antibiotic resistance.
Researchers found that HNL Dimer levels decrease rapidly within a day of successful antibiotic treatment, offering a time-saving advantage over traditional biomarkers. This study confirms the previous promising results and provides valuable insights for early diagnosis and treatment of sepsis.
A recent study revealed that nanoplastic particles impair antibiotic effects and promote bacterial resistance. The research team found that plastics like nylon bind strongly to antibiotics, increasing the risk of resistance.
The school aims to implement evidence-based practice and reduce antibiotic misuse in pediatric populations. The PCORI funding will support work with physicians, families, and providers to delay unnecessary antibiotics.
A new study suggests treating all children under 5 with azithromycin in Africa can significantly reduce child mortality. Treating older kids protects younger children from respiratory and lethal infections.
A new study found that treatment with piperacillin/tazobactam increased 90-day mortality by 5% compared to cefepime. The antibiotic depletes the gut microbiome, which plays a crucial role in metabolism, immunity, and preventing infections.
A researcher will study how plants defend themselves against nematode infections, which could lead to novel drugs or antibiotics for humans and livestock. The project aims to increase food security in Africa and Asia by understanding the molecular mechanisms behind plant resistance.
Researchers have developed a new class of antibiotics that can overcome drug-resistant bacteria by targeting the physical and functional integrity of the bacterial cell wall. This could be a game-changer in treating infections, particularly those caused by resistant strains.
A new analysis method for detecting bacteria in blood has been confirmed to provide accurate and fast results at smaller hospitals, enabling quicker antibiotic treatment. The test revealed a significant reduction in unnecessary antibiotic use and an improved patient outcome in one out of four cases.
Researchers propose a novel augmentation regimen, IPIAD, combining five generic non-oncology drugs with standard chemotherapy for pancreatic ductal adenocarcinoma. The IPIAD regimen uses repurposed drugs like irbesartan and azithromycin to potentially slow disease growth and improve outcomes.
Researchers have discovered a new way to combat fatal fungal infections by blocking the production of fatty acids, a major component of fats. The breakthrough could lead to more effective treatments against species-resistant fungi.
A new machine learning model estimates optimal treatment timing for sepsis, taking into account vital signs and lab test results to predict patient survival. The model was trained on a dataset of over 14,000 individuals with sepsis and showed improved outcomes when actual treatment matched the recommended timeline.
Research suggests that frequent antibiotic use may heighten the risk of inflammatory bowel disease among older adults. The study found a cumulative risk, with the highest risk observed 1-2 years after antibiotic exposure, particularly for those targeting gut infections.
A new study by Ochsner pharmacist Kevin Lin suggests that oral cephalosporins are as safe and effective as fluoroquinolones for treating acute kidney infections. The study's findings support the use of narrower-spectrum antibiotics to reduce antimicrobial resistance, a growing concern in healthcare.
Researchers identified a specific gut bacterium responsible for antibiotic-induced GVHD after stem cell transplants. A sugar supplement was found to improve gut health by distracting the bacteria from attacking mucin in the intestinal lining, reducing complications such as GVHD.
A preclinical study found that antibiotics have sex-specific effects on the gut microbiome of lab rats, resulting in significant changes in diversity. The findings could have implications for using antibiotics to treat or prevent bacterial infections in humans.
A study from the University of Birmingham and National Institutes of Health found that antibiotics can lead to fungal infections by disrupting the gut's immune system. Using immune-boosting drugs alongside antibiotics may reduce health risks associated with these complex infections.
Researchers developed a decision support program to reduce blood draws in pediatric intensive care units (PICU), leading to reduced antibiotic prescriptions without increasing sepsis risk. The program resulted in significant reductions in blood culture rates and unnecessary medication use.
Researchers have imaged an enzyme involved in carbapenem biosynthesis, shedding light on the process of creating a potent side chain that makes these antibiotics effective against antibiotic-resistant bacteria. The discovery could lead to improved antibiotics and new strategies for combating bacterial resistance.
Research using ring-tailed lemurs shows that fecal microbiota transplants can stabilize and restore a healthy gut microbiome after antibiotic use. The study confirms the effectiveness of this ancient treatment for reducing the negative effects of antibiotics on the gut, which can cause severe diarrhea and abdominal pain.
Researchers developed a method to determine how antibiotics interact with Gram-negative bacterial membranes, revealing that positively charged groups can facilitate passage through pores. The technique, called molecular dynamics simulation, will help design new drugs to target resistant microbes.
Polyimidazolium compounds exhibited effective antimicrobial activity against Gram-negative bacteria, including Pseudomonas aeruginosa. The inability of this pathogen to evolve resistance suggests potential as a new class of antibiotics for combating antibiotic-resistant bacteria.
A new study developed an algorithm that predicts antibiotic resistance and provides personalized treatment recommendations, reducing broad-spectrum antibiotics by 67%. The tool is a step toward reducing antibiotic resistance and improving outpatient care.
A study found that using a centralized infectious disease support program decreased overall antibiotic use and the overuse of broad-spectrum drugs in smaller hospitals. Program 3, which included a pharmacy-based initiative and expert consultation via hotline, saw a significant reduction in antibiotic use compared to baseline data.
A global survey found nearly a third of antibiotics prescribed to hospitalized children were for preventive use, contradicting current guidelines. The study highlights the need for improved antibiotic prescribing practices and education for health professionals.
A new study suggests that integrated sepsis screening and treatment protocols can increase the use of broad-spectrum antibiotics, leading to higher healthcare facility-onset C. difficile infection (CDI) rates. Researchers found an increased rate of HCFO CDI during and following sepsis care bundle implementation.
A recent study found that broad-spectrum antibiotics can raise the risk of complications from stem cell transplantation, including graft-versus-host disease. The study suggests that selecting antibiotics that spare
A new antibiotic, Debio 1452, shows promise in selectively targeting Staphilococcal pathogens while sparing the gut microbiome. Conventional broad spectrum antibiotics cause significant damage to the gut microbiome.
A study found that an outpatient antimicrobial stewardship intervention lost its initial benefits after discontinuing audit and feedback to clinicians. The program reduced broad-spectrum antibiotic prescribing rates by nearly 50 percent initially, but saw a significant increase in prescriptions after termination of the feedback component.
A recent study published in JAMA Pediatrics found a significant association between the use of broad-spectrum antibiotics before age 2 and an increased risk of obesity. The researchers analyzed data from over 1,000 children and found that greater antibiotic exposure was linked to higher rates of obesity and being overweight or obese.
Narrow-spectrum antibiotics, such as ampicillin and penicillin, are equally effective as broad-spectrum antibiotics in treating less severe childhood pneumonia. The study, published in Pediatrics, compared outcomes among children hospitalized with pneumonia between 2005 and 2011, receiving either narrow-spectrum or broad-spectrum antib...
A recent study by University of Melbourne researcher Dr. Patrick Charles found that only 5% of community-acquired pneumonia cases required broad-spectrum antibiotics, while most were caused by easy-to-treat bacteria or respiratory viruses. The study suggests that current Australian guidelines for prescribing antibiotics are appropriate...
Research shows a decrease in antibiotic prescriptions in the US, but an increase in broad-spectrum antibiotic use, which can lead to antibiotic resistance. This shift poses significant global public health concerns, particularly for treating infections like HIV, tuberculosis, and malaria.